You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

28 Results
Guidelines and Advice
Status: Archived
ID: CED 10
Sep 2008
Guidelines and Advice
Status: Archived
ID: CED 9
Aug 2008
Guidelines and Advice
Status: Archived
ID: CED 8
Jul 2008
Guidelines and Advice
Status: Archived
ID: CED 7
Feb 2008
Guidelines and Advice
Status: Archived
ID: 1-13
Sep 2008
Guidelines and Advice
Status: Archived
ID: 3-19
Feb 2008
Guidelines and Advice
Status: Education and Information
ID: 19-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 16-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 6-14
Dec 2008
Guidelines and Advice
Status: Archived
ID: 6-9
Jan 2008
Statistical Reports
Dec 2008
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
iMAtinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024

Pages